VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,436,000 | -70.4% | 151,500 | -73.0% | 0.30% | -75.0% |
| Q3 2019 | $15,011,000 | +96.4% | 562,000 | +88.0% | 1.20% | +158.8% |
| Q2 2019 | $7,642,000 | +15.5% | 299,000 | +1.4% | 0.46% | -10.3% |
| Q1 2019 | $6,614,000 | +50.0% | 295,000 | +41.1% | 0.52% | +66.8% |
| Q4 2018 | $4,408,000 | +6.3% | 209,000 | -6.7% | 0.31% | -2.8% |
| Q3 2018 | $4,148,000 | – | 224,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |